Gary S. Nabors
Gary S. Nabors publishes mostly in Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology, on topics such as Research on Leishmaniasis Studies, Bacillus and Francisella bacterial research and Trypanosoma species research and implications.
- World rank
- #1,587,921 of 7,710,434 ranked researchers
- Rank in United States
- #494,536 of 1,627,098
- Works
- 23
- Citations
- 1.7k
- Citations per work
- 73.7
What does Gary S. Nabors research?
Gary S. Nabors's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1354.8%
- Medicine1354.8%
- Life Sciences627.5%
- Everything else417.7%
- 1Epidemiology29% of their works
- 2Public Health, Environmental and Occupational Health14% of their works
- 3Molecular Biology13% of their works
- 4Infectious Diseases11% of their works
- 5Genetics8% of their works
- 6Immunology6% of their works
Research topics
- Research on Leishmaniasis Studies
- Bacillus and Francisella bacterial research
- Trypanosoma species research and implications
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Bacterial Genetics and Biotechnology
- Bacterial Infections and Vaccines
- Viral Infections and Outbreaks Research
Which keywords describe Gary S. Nabors's research?
The keywords of their largest research topics: Epidemiology, Drug Resistance, Pathogenesis, Vaccine Development, Immunity, Leishmaniasis, Treatment and Anthrax.
- Outbreak
- Gene Regulation
- Bacterial Physiology
- Respiratory Syncytial Virus
- Human Metapneumovirus
- Vaccine
- Trypanosoma cruzi
- Anthrax
- Leishmaniasis
- Vaccine Development
- Drug Resistance
- Epidemiology
- Pathogenesis
- Immunity
- Treatment
- Chagas Disease
- Tularemia
- Community-Acquired Pneumonia
- Pneumococcal Conjugate Vaccine
- Bacterial Meningitis
- Ebola Virus
- Neisseria meningitidis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Epidemiology285 topics
- Drug Resistance152 topics
- Pathogenesis133 topics
- Vaccine Development132 topics
- Immunity112 topics
- Leishmaniasis81 topic
- Treatment81 topic
- Anthrax71 topic
- Chagas Disease71 topic
- Trypanosoma cruzi71 topic
- Tularemia71 topic
- Vaccine62 topics
- Community-Acquired Pneumonia51 topic
- Human Metapneumovirus51 topic
- Pneumococcal Conjugate Vaccine51 topic
- Respiratory Syncytial Virus51 topic
- Bacterial Meningitis31 topic
- Bacterial Physiology31 topic
- Ebola Virus31 topic
- Gene Regulation31 topic
- Neisseria meningitidis31 topic
- Outbreak31 topic
Where does Gary S. Nabors work?
Gary S. Nabors's main affiliation in the publication record is Emergent BioSolutions (United States), United States.
How many publications and citations does Gary S. Nabors have?
OpenAlex counts 23 works and 1,695 citations for Gary S. Nabors, an h-index of 18, ranking #1,587,921 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gary S. Nabors. Posts are plain text and can be reported.